Clinical trial
A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention of…
NCT00455442 · Corcept Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00455442 |
|---|---|
| Title | A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain |
| Official title | A Two-Week, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain in Healthy Male Volunteers |
| Lead sponsor | Corcept Therapeutics, Industry |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Weight-Gain Prevention |
| Intervention type | Drug |
| Interventions | Mifepristone |
| Enrollment | 57 |
| Start date | Mar 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Apr 3, 2007 |
| Last update posted | Sep 19, 2008 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: